- CpG Oligodeoxynucleotide1826 combined with radioresistant cancer cell…
Number of the records: 1  

CpG Oligodeoxynucleotide1826 combined with radioresistant cancer cell vaccine confers significant antitumor effects

  1. TitleCpG Oligodeoxynucleotide1826 combined with radioresistant cancer cell vaccine confers significant antitumor effects / X.B. Zhuang ... [et al.]
    Another responsib. Zhuang, X.B. (Author)
    Translated titleCpG oligodeoxynukleotid 1826 v kombinácii s vakcínou rádiorezistentných nádorových buniek dodáva výrazné protinádorové účinky
    Phys.des.ilustr., grafy, obr., tab.
    NoteBibliogr. odkazy. Res. angl.
    In Neoplasma. -- ISSN 0028-2685. -- Vol. 62, no. 6 (2015), s. 905-913
    Call numberC 720
    MeSH Subject Lewisov pľúcny karcinóm - imunológia - terapia - rádioterapia
    imunoterapia
    vakcíny protinádorové - imunológia
    oligodeoxyribonukleotidy - farmakológia - imunológia
    faktor nekrotizujúci nádory, alfa - krv
    interleukín-10 - krv
    receptor programovanej bunkovej smrti 1
    apoptóza
    prežívanie
    myši
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.